Table 1.
Demographic characteristics of COVID-19 vaccine recipients.
| Parameters | Frequency (percentage) |
|---|---|
| Age | |
| 12–19 yrs | 1,043 (3.7%) |
| 20–29 yrs | 7,161 (25.5%) |
| 30–39 yrs | 8,791(31.4%) |
| 40–49 yrs | 5,059 (18%) |
| 50–59 yrs | 3,303 (11.8%) |
| 60–69 yrs | 2,011(7.2%) |
| 70–79 yrs | 496 (1.77%) |
| 80–89 yrs | 147 (0.5%) |
| 90–96 yrs | 20 (0.07%) |
| Gender | |
| Male | 12,800 (45.7%) |
| Female | 15,231 (54.3%) |
| Nationality | |
| Saudi | 24,683 (88.1%) |
| Non-Saudi | 3,348 (11.9%) |
| Region | |
| Al Baha | 176 (0.6%) |
| Al Jawf | 175 (0.6%) |
| Al Qassim | 976 (3.5%) |
| Asir | 952 (3.4%) |
| Hail | 281 (1%) |
| Jazan | 355 (1.3%) |
| Madinah | 1,415 (5%) |
| Makkah Al Mukarramah | 7,810 (27.9%) |
| Najran | 195 (0.7%) |
| Northern borders | 141 (0.5%) |
| Riyadh | 10,826 (38.6%) |
| Eastern region | 4,354 (15.5%) |
| Tabuk | 375 (1.3) |
| Vaccine type received | |
| Moderna | 319 (1.1%) |
| Oxford-AstraZeneca | 12,601 (45%) |
| Pfizer-BioNTech | 15,111 (53.9%) |
| Vaccine dose received | |
| 1 | 21,126 (75.4%) |
| 2 | 6,822 (24.3%) |
| 3 | 83 (0.3%) |
| Chronic diseases | |
| Diabetes | 5 (0.0178%) |
| Hypertension | 6 (0.0214%) |
| Asthma | 1 (0.0035%) |
| Coronary heart disease | 1 (0.0035%) |